Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy requires a multimodal approach including ECG, echocardiography, cardiac magnetic resonance, and genetic testing to prevent sudden cardiac death.
HypertrofickĂĄ kardiomyopatie (HKMP) je jednou z nejÄastÄjĹĄĂch pĹĂÄin nĂĄhlĂŠ smrti mladĂ˝ch sportovcĹŻ do 35 let. JejĂ fenotypickĂ˝ projev se do znaÄnĂŠ mĂry mĹŻĹže podobat fyziologickĂŠ reakci myokardu na vysokou trĂŠninkovou zĂĄtÄĹž, kdy hovoĹĂme o takzvanĂŠm atletickĂŠm (sportovnĂm) srdci. Tyto dva stavy je tĹeba od sebe rozliĹĄit, abychom neohrozili Ĺživot sportovce Äi sportovkynÄ s nerozpoznanou HKMP a takĂŠ abychom na druhou stranu zbyteÄnÄ nezastavili jejich sportovnĂ kariĂŠru.
M Bláha (Fri,) conducted a review in Hypertrophic cardiomyopathy and athlete's heart. Differential diagnostics (ECG, Echocardiography, MRI, Genetic testing) was evaluated. Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy requires a multimodal approach including ECG, echocardiography, cardiac magnetic resonance, and genetic testing to prevent sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: